NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • NIHR Oxford BRC impact
    • Steering Committee
    • Promoting equality, diversity and inclusion in research
    • Current Vacancies
    • Stay in Touch
    • Contact Us
  • Research

        • Research Overview
        • Clinical Research Facility
        • Health Economics
        • Ethics in the NIHR Oxford BRC
        • Medical Statistics
        • Infections in Oxfordshire Database (IORD)
        • 15 Research Themes

        • Cancer
        • Cardiovascular Medicine
        • Digital Health from Hospital to Home
        • Gene and Cell Therapy
        • Genomic Medicine
        • Imaging
        • Inflammation across Tissues
        • Life-saving Vaccines
        • Metabolic Experimental Medicine
        • Modernising Medical Microbiology and Big Infection Diagnostics
        • Musculoskeletal
        • Preventive Neurology
        • Respiratory Medicine
        • Surgical Innovation, Technology and Evaluation
        • Translational Data Science
  • Patient and Public Involvement
    • For patients and the public
    • For researchers
    • More information
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Pre-doctoral Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • PARC Programme
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events

News

You are here: Home > COVID-19 > Possible predictors of COVID-19 severity identified

Possible predictors of COVID-19 severity identified

13 November 2020 · Listed under COVID-19, Partnerships for Health, Wealth and Innovation

A study by researchers at the University of Oxford and Imperial College London have developed a checklist of potential predictors that someone may go on to develop a severe form of COVID-19.

National Cancer Institute via Unsplash

The paper, produced as part of the RECAP study, was published in the online open-access journal BMJ Open.

Doctors and other clinicians who assess people over the phone or by video need to know which symptoms to take note of when deciding which people to bring in to assess further or send to hospital. 

The study included focus groups and a consensus-building exercise involving 112 clinicians, as well as 50 interviews with patients. It came up with a preliminary list of items which are thought to be associated with a more severe disease course in the first 28 days.

These items are: pulse rate, temperature, fever symptoms (e.g. shivering, chills), respiratory rate, shortness of breath, pulse oximeter reading, post-exercise fall in pulse oximeter reading, tiredness, muscle aches, being on the UK’s ‘shielded list’ of people who have vulnerability to COVID-19, and other risk factors for poor outcome such as age over 65 and non-White ethnicity.  

Professor Trisha Greenhalgh, the NIHR Oxford BRC’s Theme Lead for Partnerships for Health, Wealth and Innovation, who led this phase of the study, said: “By tapping into the experience and wisdom of over 100 frontline clinicians, and by carefully analysing the stories told by 50 patients about their experiences, we have developed a list of things we think predict severity in the first two weeks of a COVID-19 illness.

Prof Trish Greenhalgh

“We now need to test these further to develop a formal score which we’ll be calling RECAP, which stands for REmote COVID Assessment in Primary Care.” 

Professor Simon de Lusignan, also from the University of Oxford’s Nuffield Department of Primary Care Health Sciences, said: “The draft RECAP items have been built into GP computer systems. We’re currently collecting data on these items on people suspected of having COVID-19, and we’ll be linking that data with actual outcomes of the illness to validate the score.” 

Professor Brendan Delaney from Imperial College London who will be leading the next phase of the RECAP study, said: “We very much hope that a score developed from these items will help GPs and their staff decide more precisely who needs to be rushed to hospital, who needs to be closely monitored, and who can be safely reassured. We’re still recruiting GP practices to be part of the validation phase of the study.”  

← COVID antibodies wane within months, healthcare workers study shows
Interferon-b trial shows positive results →

Other news

News Categories

News by Month

See all news

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

Oxford BRC on Social Media

  • Bluesky
  • Facebook
  • LinkedIn
  • Threads
  • Twitter
  • YouTube
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2025 NIHR Oxford Biomedical Research Centre